:: Volume 24, Issue 1 (Spring 2022) ::
EBNESINA 2022, 24(1): 79-86 Back to browse issues page
Black fungus infection and its relationship with the covid-19 disease
Yousef Alimohamadi , Mojtaba Sepandi , Kolsoom Alimohammadi
Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran , msepandi@gmail.com
Abstract:   (4117 Views)

The Covid-19 virus has infected different countries of the world since the end of 2019. To date, more than 208 million people have been infected with the disease, and more than 4 million have lost their lives. While efforts to curb the COVID-19 pandemic continue through vaccination around the world, the incidence and mortality continue to rise. Unfortunately, in the fight against the pandemic, COVID-19 patients are also at risk for some secondary infections such as mucormycosis. Mucormycosis, or black fungal disease is a rare and opportunistic infection that can spread fast in people with COVID-19. The action of this fungus is to invade the body's arteries and create clots in them. As a result of the clot, blood flow to the tissues of the body is stopped, and the tissue becomes necrotic or so-called black. Black fungus has made headlines these days during the Covid-19 epidemic, especially in India. Diabetes mellitus and the use of steroid drugs (which are prescribed to treat severe acute respiratory infections) are important risk factors for COVID-19 patients. Due to the opportunistic nature of this infection, early detection of it can reduce the severity of the disease and consequently reduce the mortality of COVID-19 patients.
 
Keywords: Mucormycosis, COVID-19, Coinfections
Full-Text [PDF 809 kb]   (552 Downloads)    
Type of Study: Review | Subject: Disaster Medicine
Received: 2021/09/30 | Accepted: 2021/11/28 | Published: 2022/03/30



XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 1 (Spring 2022) Back to browse issues page